The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 8.06 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.68 — no flag raisedOK
- Earnings quality 82/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as MIMEDX GROUP, INC. reports it. History and quarterly detail are in the app.
- Wound$276.3M
- Surgical$142.3M
Leadership changes
From MIMEDX GROUP, INC.'s own filings, the day they're filed.
- Tiffany P. Olson · Director · appointmenteff. 2024-03-01
- William Phelan · Chief Accounting Officer · appointmenteff. 2023-09-01
- Peter Carlson · Chief Financial Officer · departureeff. 2023-07-05
Latest filings
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-29
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-06-16
- DEF 14A · Annual proxy (pay & governance)2026-04-29
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about MIMEDX GROUP, INC., every answer cited to the official filings🔒
- The Intelligence Brief — added when MIMEDX GROUP, INC.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.